ProPhase Labs Inc - SIC # 8071 - MEDICAL LABORATORIES

Ticker Exchange SIC # Website Latest Ticker
PRPH Nasdaq 8071 https://www.prophaselabs.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ProPhase Labs Inc

ProPhase Labs Unveils Project ZenQ-AI - Apr 16th, 2024 12:00 pm
Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength? - Apr 15th, 2024 11:47 am
ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024 - Apr 10th, 2024 12:00 pm
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Apr 2nd, 2024 1:00 am
ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call Transcript - Mar 18th, 2024 1:20 pm
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) - Mar 18th, 2024 1:08 pm
ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives - Mar 15th, 2024 12:00 pm
PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024 - Mar 8th, 2024 1:00 pm
ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 29% Above Their Intrinsic Value Estimate - Mar 1st, 2024 11:28 am
ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART - Feb 20th, 2024 1:00 pm
ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir - Feb 14th, 2024 1:00 pm
Diamond Equity Research Releases In Depth Update Note on ProPhase Labs, Inc. (NASDAQ: PRPH) subsidiary, Pharmaloz Manufacturing, Inc. (PMI) - Feb 8th, 2024 1:00 pm
ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics - Jan 30th, 2024 1:00 pm
Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts - Jan 23rd, 2024 1:00 pm
ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024 - Jan 4th, 2024 1:00 pm
ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2023 Earnings Call Transcript - Nov 10th, 2023 6:50 pm
ProPhase Labs Inc (PRPH) Reports Mixed Q3 Results Amid Strategic Transformations - Nov 9th, 2023 2:25 pm
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023 - Nov 9th, 2023 1:00 pm
ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time - Nov 2nd, 2023 12:00 pm
ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output. - Oct 17th, 2023 12:00 pm